Table 3 Evaluation of the preliminary outcomes of the program for patients who received hormone therapy.

From: Multimedia-based hormone therapy information program for patients with prostate cancer: the result of a randomized pilot study

Outcome

MIG (n = 36)a

CG (n = 40)a

Cohen’s db

Generalized estimating equationc

Time

Group × time interaction effects

Mean

SD

Mean

SD

B (SE)

B (SE)

95% CI

Primary outcomes

 Positive thinking

  Pre-test

67.17

7.07

67.23

7.42

 < − 0.01

   

  8 weeks

68.83

7.43

67.13

8.06

0.22

− 0.10 (0.82)

1.77 (1.27)

− 0.73, 4.26

  12 weeks

68.50

8.73

66.62

7.57

0.23

− 0.28 (0.77)

1.61 (1.25)

− 0.83, 4.06

 General QOL

  Pre-test

79.86

13.95

79.18

15.42

0.05

   

  8 weeks

80.89

13.84

79.28

19.54

0.10

0.10 (2.01)

0.93 (2.77)

− 4.50, 6.35

  12 weeks

80.44

14.63

80.46

16.30

 < − 0.01

0.66 (1.73)

− 0.07 (2.48)

− 4.93, 4.79

 Prostate cancer-specific QOL

  Pre-test

116.39

18.44

115.00

20.92

0.07

   

  8 weeks

118.25

17.69

116.75

25.24

0.07

1.75 (2.58)

0.11 (3.53)

-6.81, 7.04

  12 weeks

118.19

18.57

117.35

21.92

0.04

1.39 (2.35)

0.42 (3.21)

-5.88, 6.71

 Hormone symptoms and distress

  Pre-test

85.67

14.48

84.66

15.45

0.07

   

  8 weeks

87.25

12.91

86.19

15.29

0.08

1.53 (2.34)

0.04 (2.88)

− 5.61, 5.69

  12 weeks

83.40

14.71

86.79

14.55

− 0.23

1.72 (2.21)

− 3.99 (3.18)

− 10.23, 2.24

Secondary outcomes

 Social support

  Pre-test

34.69

8.20

35.43

9.56

− 0.08

   

  8 weeks

34.89

9.04

34.33

9.38

0.06

− 1.10 (1.00)

1.29 (1.66)

− 1.95, 4.54

  12 weeks

34.44

10.00

33.49

9.15

0.01

− 1.36 (1.50)

1.11 (2.05)

− 2.90, 5.12

 Self-efficacy

  Pre-test

29.44

5.84

29.90

5.32

− 0.08

   

  8 weeks

29.08

4.00

30.18

5.16

− 0.24

0.28 (0.65)

− 0.64 (0.97)

− 2.53, 1.26

  12 weeks

30.47

5.69

29.70

5.02

0.14

− 0.07 (0.77)

1.10 (1.20)

− 1.25, 3.44

  1. Cases included in data analysis at pre-test, 8 weeks, and 12 weeks: MIG—36, 36, and 36, respectively, CG—40, 40, and 37, respectively.
  2. aGeneralized estimating equations were employed to assess changes over time, with the pre-test serving as the reference group. All p values > 0.05.
  3. bCohen’s d = (Mean in MIG − Mean in CG)/SDpooled.
  4. cControl covariates: annual household income, occupational status, and time since diagnosis.
  5. CG control group, CI confidence interval, MIG multimedia information group, QOL quality of life, SD standard deviation, SE standard error.